[OS13] Bacteria 2 (Respiratory)

10:50 AM - 11:05 AM JST(1:50 AM - 2:05 AM UTC)

[OS13-4] Economic loss due to Actinobacillus pleuropneumonia demonstrated by Ceva Lung Program

Michael Groes Christiansen¹, Charlotte Sonne Christensen², Michael Albin², *PREBEN MORTENSEN³ (1. SEGES Innovation (Denmark), 2. Ceva Animal Health A/S (Denmark), 3. Ceva Corporate Swine (France))

Keywords:

App,CLP,APPI,Ceva Lung Program,Economic losses,losses/APPI,Pleurisy